Product image of Levetiracetam Neuraxpharm (Levetiracetam) supplied by GNH India

Levetiracetam Neuraxpharm

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Neuraxpharm (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Neuraxpharm, is an antiepileptic presented as an oral dosage form for oral use. It is employed to control partial, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure management.

GNH India supplies Levetiracetam Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Neuraxpharm Bohemia S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an antiepileptic drug indicated for several seizure types.
  • Partial seizures: reduces the frequency of focal seizures in patients with epilepsy.
  • Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy.
  • Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilising neuronal membranes. This action reduces neuronal hyper‑excitability and limits the propagation of seizure activity across the central nervous system.

Side Effects

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Drowsiness: feeling unusually sleepy or fatigued.
  • Dizziness: sensation of light‑headedness or imbalance.
  • Headache: mild to moderate cranial pain.
  • Irritability: increased mood swings or agitation.
  • Nausea: upset stomach or feeling of queasiness.
  • Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Mood changes: depression, suicidal thoughts, or severe anxiety.
  • Blood disorders: low white blood cell or platelet counts.
  • Hepatic dysfunction: signs of liver injury such as jaundice.
  • Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Multiorgan failure: extremely rare but life‑threatening systemic involvement.

Precautions & Warnings

  • Before initiating therapy, consider the following safety measures.
  • Renal function: assess kidney performance and adjust dose if necessary.
  • Pregnancy status: evaluate risks and benefits, as safety data are limited.
  • Concomitant CNS depressants: monitor for enhanced sedation.
  • Psychiatric history: watch for worsening mood or behavioral changes.
  • Alcohol consumption: advise moderation to avoid additive CNS effects.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels.
  • Phenobarbital: can lower levetiracetam concentrations.
  • Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely)

  • Alcohol: additive CNS depression, monitor sedation.
  • Opioids: increased risk of respiratory depression.
  • Other antiepileptics: potential additive side‑effects, adjust monitoring.

Frequently Asked Questions

Levetiracetam Neuraxpharm is used to treat various types of epilepsy, including partial seizures, generalized tonic‑clonic seizures, and myoclonic seizures. It helps reduce the frequency and severity of seizure episodes in patients diagnosed with these conditions.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By stabilising neuronal firing and decreasing hyper‑excitability, it limits the spread of seizure activity throughout the brain.

The dosage of Levetiracetam Neuraxpharm is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and seizure type. Only a qualified prescriber should set the appropriate dose.

Safety data for levetiracetam in pregnancy and lactation are limited. Prescribers should weigh potential benefits against possible risks and discuss options with the patient. Breastfeeding decisions should also consider the drug’s presence in milk and infant exposure.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It generally has fewer drug‑enzyme interactions, but individual efficacy and tolerability vary, so clinicians choose based on patient profile.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Levetiracetam Neuraxpharm is administered orally, typically as tablets or oral solution, according to the prescriber’s instructions. It may be taken with or without food, and the dose schedule should be followed consistently.

Serious risks include severe allergic reactions, mood changes such as depression or suicidal thoughts, and rare blood disorders. Patients should be monitored for any signs of rash, mood alteration, or abnormal laboratory values and seek medical attention promptly.

Patients with known hypersensitivity to levetiracetam or any of its excipients should avoid the product. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting anticonvulsants without proper monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT